400% price hike for generic drug a ‘moral requirement,’ Missouri pharma CEO says

(By Alia Paavola for Becker’s Hospital Review)

Nostrum Laboratories, a Missouri-based drugmaker, raised the price of a generic antibiotic 400 percent to more than $2,000 per bottle, and its CEO is defending the price hike, according to The Financial Times. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

 

 

Leave a Reply